Cargando…
Harms and benefits of adoptive immunotherapy for postoperative hepatocellular carcinoma: an updated review
The harms and benefits of adoptive immunotherapy (AIT) for patients with postoperative hepatocellular carcinoma (HCC) are controversial among studies. This study aims to update the current evidence on efficacy and safety of AIT for patients with HCC who have received curative therapy. Electronic dat...
Autores principales: | Yuan, Bao-Hong, Li, Ru-Hong, Yuan, Wei-Ping, Yang, Tian, Tong, Tie-Jun, Peng, Ning-Fu, Li, Le-Qun, Zhong, Jian-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392348/ https://www.ncbi.nlm.nih.gov/pubmed/28061472 http://dx.doi.org/10.18632/oncotarget.14507 |
Ejemplares similares
-
Timely meta-analysis on the efficacy of adoptive immunotherapy for hepatocellular carcinoma patients after curative therapy
por: Mo, Han-Yue, et al.
Publicado: (2017) -
Adoptive Immunotherapy in Postoperative Hepatocellular Carcinoma: A Systemic Review
por: Xie, Feng, et al.
Publicado: (2012) -
Cancer immunotherapy: Benefit and harm?
por: Characiejus, Dainius
Publicado: (2012) -
Perioperative entecavir for patients with HBV-related hepatocellular carcinoma and low levels of viral DNA: analysis using propensity score matching
por: Yuan, Bao-Hong, et al.
Publicado: (2017) -
Postoperative Use of the Chemopreventive Vitamin K2 Analog in Patients with Hepatocellular Carcinoma
por: Zhong, Jian-Hong, et al.
Publicado: (2013)